1. Lockey, Richard F., Linda M. Benedict, Paul C. Turkeltaub, Samuel C. Bukantz. Fatalities from immunotherapy (IT) and skin testing (ST). J. Allergy Clin. Immunol. 79 (4): 660-677, 1987.
2. Jacobs, Robert L., Goeffrey W. Rake, Jr., et. al. Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade. J. Allergy Clin. Immunol. 68 (2): 125-127, August 1981.
3. Hunt, K. J., M. D. Valentine, A. K. Sobotka, A. W. Benton, F. J. Amodio, L. M. Lichtenstein. A controlled trial of immunotherapy in insect hypersensitivity. New Eng. J. Med. 299: 157-161, July 27, 1978.
4. Summary of data from BB-IND 1292 clinical studies, 1978-79, on Hollister-Stier products.
5. Amodio, F., L. Markley, M. D. Valentine, A. K. Sobotka, L. M. Lichtenstein. Maintenance immunotherapy for Hymenoptera sensitivity. J. Allergy Clin. Immunol. 61 (3): 134, 1978.
6. Reisman, R. E., Allergy Principles and Practice. E. Middleton, C. E. Reed, E. F. Ellis, ed. C. V. Mosby Co., 1978.
7. Sobotka, A. K., N. F. Adkinson, Jr., M. D. Valentine, L. M. Lichtenstein. Allergy to insect stings. IV. Diagnosis by R.A.S.T. J. Immunol. 121 (6): 2477-2484, 1978.
8. Hunt, K. J., M. D. Valentine, A. K. Sobotka, L. M. Lichtenstein. Diagnosis of allergy to stinging insects by skin testing with Hymenoptera venoms. Annals Int. Med. 85: 56-59, 1976.
9. Annals of Allergy, Asthma and Immunology. Inhibitors of angiotensin II: Potential hazards for patients at risk for anaphylaxis. Editorial. 78: 527-529, June 1997.
10. Pharm. Ind. (Germany). Anaphylactoid reactions in patients treated with ACE inhibitor treatment in combination with desensitization treatment or after insect bites. 56 (9): IX226-227, 1994.
11. Tunon-De-Lara, J. M., et al. ACE inhibitors and anaphylactoid reactions during venom immunotherapy. The Lancet (United Kingdom). 340 (8824): 908, Oct. 10, 1992.
12. Weinstien, A. M., B. D. Dubin, W. K. Podleski, S. L. Spector, R. S. Farr. Asthma and pregnancy. JAMA. 124 (11): 1161-1165, 1979.
13. Reid, M. J., R. F. Lockey, P. C. Turkletaub, T. A. E. Platts-Mills. Survey of fatalities from skin testing and immunotherapy. J. Allergy Clin. Immunol. 92 (1): 6-15, July 1993.
14. Reid, M. J., G. Gurka. Deaths associated with skin testing and immunotherapy. J. Allergy Clin. Immunol. 97 (1) Part 3:231, Abstract 195, January 1996.
15. Thompson, R. A. et al. Report of a WHO/IUIS working group. The current status of allergen immunotherapy (hyposensitization). Allergy. 44: 369-379, 1989.
16. Malling, H.J., B. Weeke, et al. The European Academy of Allergology and Clinical Immunology. Position Papers. Allergy. 48 (Supplement 14): 9-82, 1993.
17. Pipkorn, Ulf. Pharmacological influence of anti-allergic medication on In Vivo allergen testing. Allergy. 43: 81-86, 1988.
18. Andersson, M. U. Pipkorn. Inhibition of the dermal immediate allergic reaction through prolonged treatment with topical glucocorticosteroids. J. Allergy Clin. Immunol. 79 (2): 345-349, February 1987.
19. Rao, Kamineni S., et al. Duration of suppressive effect of tricyclic anti-depressants on histamine induced wheal and flare reactions on human skin. J. Allergy Clin. Immunol. 82: 752-757, November 1988.
20. Pipkorn, Ulf, M. Andersson. Topical dermal anesthesia inhibits the flare but not the wheal response to allergen and histamine in the skin prick test. Clinical Allergy. 17: 307-311, 1987.
21. DuBuske, L. M., C. J. Ling, A. L. Sheffer. Special problems regarding allergy immunotherapy. Immunol. Allergy Clin. North Am. (USA). 12 (1): 145-175, 1992.
22. Graft, D., K. Schuberth, A. Kagey-Sobotka, K. Kwiterovich, Y. Niv, L. Lichtenstein, M. Valentine. Assessment of prolonged venom immunotherapy in children. J. Allergy Clin. Immunol. 80 (2): 162-169, August 1987.
23. Peebles, Ray Stokes, Jr., B. Bochner, Howard J. Zeitz, ed. Anaphylaxis in the elderly. Immunol. Allergy Clin. of North Am. 13 (3): 627-646, August 1993.
HONEY BEE HYMENOPTERA VENOM MULTIDOSE
honey bee hymenoptera venom multidose injection, powder, lyophilized, for solution |
| Product Information | | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:65044-9940 | | Route of Administration | SUBCUTANEOUS, PERCUTANEOUS | DEA Schedule | | |
| Active Ingredient/Active Moiety | | Ingredient Name | Basis of Strength | Strength | | APIS MELLIFERA VENOM (APIS MELLIFERA VENOM) | APIS MELLIFERA VENOM | 100 ug in 1 mL | |
| Inactive Ingredients | | Ingredient Name | Strength | | mannitol | | |
|
| Packaging | | # | Item Code | Package Description | | 1 | NDC:65044-9940-5 | 5.5 mL in 1 VIAL | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | BLA | BLA103882 | 10/16/1979 | | |
WHITE FACED HORNET HYMENOPTERA VENOM MULTIDOSE
white faced hornet hymenoptera venom multidose injection, powder, lyophilized, for solution |
| Product Information | | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:65044-9941 | | Route of Administration | SUBCUTANEOUS, PERCUTANEOUS | DEA Schedule | | |
| Active Ingredient/Active Moiety | | Ingredient Name | Basis of Strength | Strength | | DOLICHOVESPULA MACULATA VENOM PROTEIN (DOLICHOVESPULA MACULATA VENOM PROTEIN) | DOLICHOVESPULA MACULATA VENOM PROTEIN | 100 ug in 1 mL | |
| Inactive Ingredients | | Ingredient Name | Strength | | mannitol | | | sodium chloride | | | potassium chloride | | | acetic acid | | | alanine | | |
|
| Packaging | | # | Item Code | Package Description | | 1 | NDC:65044-9941-5 | 5.5 mL in 1 VIAL | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | BLA | BLA103885 | 10/16/1979 | | |
YELLOW HORNET HYMENOPTERA VENOM MULTIDOSE
yellow hornet hymenoptera venom multidose injection, powder, lyophilized, for solution |
| Product Information | | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:65044-9942 | | Route of Administration | SUBCUTANEOUS, PERCUTANEOUS | DEA Schedule | | |
| Active Ingredient/Active Moiety | | Ingredient Name | Basis of Strength | Strength | | DOLICHOVESPULA ARENARIA VENOM PROTEIN (DOLICHOVESPULA ARENARIA VENOM PROTEIN) | DOLICHOVESPULA ARENARIA VENOM PROTEIN | 100 ug in 1 mL | |
| Inactive Ingredients | | Ingredient Name | Strength | | mannitol | | | sodium chloride | | | potassium chloride | | | acetic acid | | | alanine | | |
|
| Packaging | | # | Item Code | Package Description | | 1 | NDC:65044-9942-5 | 5.5 mL in 1 VIAL | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | BLA | BLA103886 | 10/16/1979 | | |
WASP HYMENOPTERA VENOM MULTIDOSE
wasp hymenoptera venom multidose injection, powder, lyophilized, for solution |
| Product Information | | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:65044-9943 | | Route of Administration | SUBCUTANEOUS, PERCUTANEOUS | DEA Schedule | | |
| Active Ingredient/Active Moiety | | Ingredient Name | Basis of Strength | Strength | | POLISTES ANNULARIS VENOM PROTEIN (POLISTES ANNULARIS VENOM PROTEIN) | POLISTES ANNULARIS VENOM PROTEIN | 25 ug in 1 mL | | POLISTES EXCLAMANS VENOM PROTEIN (POLISTES EXCLAMANS VENOM PROTEIN) | POLISTES EXCLAMANS VENOM PROTEIN | 25 ug in 1 mL | | POLISTES FUSCATUS VENOM PROTEIN (POLISTES FUSCATUS VENOM PROTEIN) | POLISTES FUSCATUS VENOM PROTEIN | 25 ug in 1 mL | | POLISTES METRICUS VENOM PROTEIN (POLISTES METRICUS VENOM PROTEIN) | POLISTES METRICUS VENOM PROTEIN | 25 ug in 1 mL | |
| Inactive Ingredients | | Ingredient Name | Strength | | mannitol | | | sodium chloride | | | potassium chloride | | | acetic acid | | | alanine | | |
|
| Packaging | | # | Item Code | Package Description | | 1 | NDC:65044-9943-5 | 5.5 mL in 1 VIAL | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | BLA | BLA103884 | 10/16/1979 | | |
YELLOW JACKET HYMENOPTERA VENOM MULTIDOSE
yellow jacket hymenoptera venom multidose injection, powder, lyophilized, for solution |
| Product Information | | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:65044-9944 | | Route of Administration | SUBCUTANEOUS, PERCUTANEOUS | DEA Schedule | | |
| Active Ingredient/Active Moiety | | Ingredient Name | Basis of Strength | Strength | | VESPULA GERMANICA VENOM PROTEIN (VESPULA GERMANICA VENOM PROTEIN) | VESPULA GERMANICA VENOM PROTEIN | 20 ug in 1 mL | | VESPULA MACULIFRONS VENOM PROTEIN (VESPULA MACULIFRONS VENOM PROTEIN) | VESPULA MACULIFRONS VENOM PROTEIN | 20 ug in 1 mL | | VESPULA PENSYLVANICA VENOM PROTEIN (VESPULA PENSYLVANICA VENOM PROTEIN) | VESPULA PENSYLVANICA VENOM PROTEIN | 20 ug in 1 mL | | VESPULA SQUAMOSA VENOM PROTEIN (VESPULA SQUAMOSA VENOM PROTEIN) | VESPULA SQUAMOSA VENOM PROTEIN | 20 ug in 1 mL | | VESPULA VULGARIS VENOM PROTEIN (VESPULA VULGARIS VENOM PROTEIN) | VESPULA VULGARIS VENOM PROTEIN | 20 ug in 1 mL | |
| Inactive Ingredients | | Ingredient Name | Strength | | mannitol | | | sodium chloride | | | potassium chloride | | | acetic acid | | | alanine | | |
|
| Packaging | | # | Item Code | Package Description | | 1 | NDC:65044-9944-5 | 5.5 mL in 1 VIAL | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | BLA | BLA103887 | 10/16/1979 | | |
MIXED VESPID HYMENOPTERA VENOM MULTIDOSE
mixed vespid hymenoptera venom multidose injection, powder, lyophilized, for solution |
| Product Information | | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:65044-9945 | | Route of Administration | SUBCUTANEOUS | DEA Schedule | | |
| Active Ingredient/Active Moiety | | Ingredient Name | Basis of Strength | Strength | | DOLICHOVESPULA MACULATA VENOM PROTEIN (DOLICHOVESPULA MACULATA VENOM PROTEIN) | DOLICHOVESPULA MACULATA VENOM PROTEIN | 100 ug in 1 mL | | DOLICHOVESPULA ARENARIA VENOM PROTEIN (DOLICHOVESPULA ARENARIA VENOM PROTEIN) | DOLICHOVESPULA ARENARIA VENOM PROTEIN | 100 ug in 1 mL | | VESPULA GERMANICA VENOM PROTEIN (VESPULA GERMANICA VENOM PROTEIN) | VESPULA GERMANICA VENOM PROTEIN | 20 ug in 1 mL | | VESPULA MACULIFRONS VENOM PROTEIN (VESPULA MACULIFRONS VENOM PROTEIN) | VESPULA MACULIFRONS VENOM PROTEIN | 20 ug in 1 mL | | VESPULA PENSYLVANICA VENOM PROTEIN (VESPULA PENSYLVANICA VENOM PROTEIN) | VESPULA PENSYLVANICA VENOM PROTEIN | 20 ug in 1 mL | | VESPULA SQUAMOSA VENOM PROTEIN (VESPULA SQUAMOSA VENOM PROTEIN) | VESPULA SQUAMOSA VENOM PROTEIN | 20 ug in 1 mL | | VESPULA VULGARIS VENOM PROTEIN (VESPULA VULGARIS VENOM PROTEIN) | VESPULA VULGARIS VENOM PROTEIN | 20 ug in 1 mL | |
| Inactive Ingredients | | Ingredient Name | Strength | | mannitol | | | sodium chloride | | | potassium chloride | | | acetic acid | | | alanine | | |
|
| Packaging | | # | Item Code | Package Description | | 1 | NDC:65044-9945-5 | 5.5 mL in 1 VIAL | |
|
| Marketing Information | | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | | BLA | BLA103883 | 12/11/1980 | | |
| Labeler - Jubilant HollisterStier LLC (069263643) |
| Registrant - Jubilant HollisterStier LLC (069263643) |
| Establishment |
| Name | Address | ID/FEI | Operations |
| Jubilant HollisterStier LLC | | 069263643 | manufacture |
Revised: 12/2011 Jubilant HollisterStier LLC
